ArticleCureus2024
Unraveling the Clinical Quandary: Cryptic Tuberculosis or Splenogonadal Malignancy?
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis continues to persist as a significant health problem in multiple parts of the world despite global efforts to eradicate it. A high variability in the clinical manifestation hinders the early diagnosis. Atypical presentations like "cryptic tuberculosis" lack classic clinical and radiological features of the disease and can mimic metastatic cancer, posing a diagnostic challenge. Herein, we report a case of a 70-year-old male with complaints of chronic abdominal pain, who was presumed to have malignant disease of the spleen and testis after clinical and radiological assessment. However, the histopathology and microscopy revealed features of tuberculosis, and a culture test confirmed the diagnosis. Hence, clinicians should be vigilant of the ambiguity of symptoms, especially in immunosuppressed patients and among residents of endemic areas. This can target aggressive efforts to diagnose and treat such unusual presentations of tuberculosis, avoiding unwanted mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.